Three-Year Survival Following Multivessel Percutaneous Coronary Intervention With Bare-Metal or Drug-Eluting Stents in Unselected Patients

This publication has 26 references indexed in Scilit:

• Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
  EuroIntervention, 2008
• Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
  Annals of Internal Medicine, 2007
• Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease
  Circulation, 2007
• Clinical Outcomes and Stent Thrombosis Following Off-Label Use of Drug-Eluting Stents
  JAMA, 2007
• Outcomes and Complications Associated With Off-Label and Untested Use of Drug-Eluting Stents
  JAMA, 2007
• Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
  Published by Elsevier ,2007
• One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A meta-analysis of individual patient data from randomized clinical trials
  The Journal of Thoracic and Cardiovascular Surgery, 2005
• Five-Year Outcomes After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease
  Journal of the American College of Cardiology, 2005
• Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results
  Journal of the American College of Cardiology, 2004
• Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
  The Lancet, 1995